601-615 of 894
What to Know About a State-of-the-Art Approach to GIST Treatment
Medical Breakthroughs from Penn MedicineWhat to Know About a State-of-the-Art Approach to GIST Treatment
Shira Johnson, MD
Ronald DeMatteo, MD, FACS
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Medical Breakthroughs from Penn MedicineCAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Shira Johnson, MD
Robert Vonderheide, MD
Rethinking Nicotine: The Campaign to Break the World's Tobacco Habit
Primary Care TodayRethinking Nicotine: The Campaign to Break the World's Tobacco Habit
Brian P. McDonough, MD, FAAFP
Jennifer Caudle, DO, FACOFP
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA Drug Information UpdatesFDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
- advertisement
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Project Oncology®Pancreatic Cancer: The Hunt to Catch a Silent Killer
John Russell, MD
Harish Lavu, MD
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
NutritionEdgeThe CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
Kathy King, RDN
Lise Alschuler, ND
Jennifer Caudle, DO, FACOFP
Knowing your Patient's Melanoma Risk Factors
Everyday Family MedicineKnowing your Patient's Melanoma Risk Factors
Jennifer Caudle, DO, FACOFP
- advertisement
Linking p53 Variation to Breast Cancer Risk in African American Women
Project Oncology®Linking p53 Variation to Breast Cancer Risk in African American Women
Brian P. McDonough, MD, FAAFP
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Project Oncology®FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Project Oncology®Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Jennifer Caudle, DO, FACOFP
Major Kenneth Lee, IV, MD, PhD
